JAK2, the JAK2 V617F mutant and cytokine receptors

Pathologie Biologie

Volumn 55, Issue 2, 2007, Pages 88-91

  Staerk, J ^a,b   Kallin, A ^b   Royer, Y ^a,b   Diaconu, C C ^a,b,d   Dusa, A ^a,b   Demoulin, J B ^b   Vainchenker, W ^c   Constantinescu, S N ^a,b,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

Author keywords

Erythropoietin; IGF1; JAK2; Thrombopoietin

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 2 V617F; JANUS KINASE 3; PEPTIDE; PHENYLALANYLGLUTAMYLARGINYLMETHIONINE; PROTEIN SH2; PROTEIN TYK2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT PROTEIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; JAK1 PROTEIN, HUMAN; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, MOUSE; MPL PROTEIN, HUMAN; PROTEIN KINASE TYK2; TYK2 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CELL STIMULATION; CYTOSOL; ENZYME ACTIVATION; ERYTHROID PRECURSOR CELL; GENE MUTATION; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; HUMAN; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MYELOID METAPLASIA; NONHUMAN; POLYCYTHEMIA VERA; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; SOMATIC MUTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; AMINO ACID SUBSTITUTION; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; MISSENSE MUTATION; MOUSE; MYELOPROLIFERATIVE DISORDER; PHYSIOLOGY; POINT MUTATION; PROTEIN TRANSPORT; REVIEW; SRC HOMOLOGY DOMAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CELLS, CULTURED; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; JANUS KINASE 1; JANUS KINASE 2; MICE; MUTATION, MISSENSE; MYELOPROLIFERATIVE DISORDERS; POINT MUTATION; PROTEIN TRANSPORT; RECEPTORS, CYTOKINE; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, THROMBOPOIETIN; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TYK2 KINASE;

EID: 33947128676     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.06.003     Document Type: Article

References (19)

1. James C., Ugo V., Le Couedic J.P., Staerk J., Delhommeau F., Lacout C., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144
2. Baxter E.J., Scott L.M., Campbell P.J., East C., Fourouclas N., Swanton S., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054
3. Kralovics R., Passamonti F., Buser A.S., Teo S.S., Tiedt R., Passweg J.R., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N. Engl. J. Med. 352 (2005) 1779
4. Levine R.L., Wadleigh M., Cools J., Ebert B.L., Wernig G., Huntly B.J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387
5. Zhao R., Xing S., Li Z., Fu X., Li Q., Krantz S.B., et al. Identification of an acquired JAK2 mutation in polycythemia vera. J. Biol. Chem. 280 (2005) 22788
6. Zhao Z.J., Krantz S.B., Vainchenker W., and Casadevall N. Constantinescu SN. Role of tyrosine kinases and phosphatases in Polycythemia Vera. Semin Hematol. 42 (2005) 221
7. Vainchenker W., and Constantinescu S.N. A unique activating mutation in JAK2 is at the origin of Polycythemia Vera and allows a new classification of myeloproliferative diseases. Hematology (Am Soc Hematol Educ Program) (2005) 195
8. Lindauer K., Loerting T., Liedl K.R., and Kroemer R.T. Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Eng. 14 (2001) 27
9. Luo H., Rose P., Barber D., Hanratty W.P., Lee S., Roberts T.M., et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 17 (1997) 1562
10. Staerk J., Kallin A., Demoulin J.-B., Vainchenker W., and Constantinescu S.N. JAK1 and Tyk2 activation by the homologous Polycythemia Vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J. Biol. Chem. 280 (2005) 41893
11. Huang L.J., Constantinescu S.N., and Lodish H.F. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol. Cell 8 (2001) 1327
12. Royer Y., Staerk J., Costuleanu M., Courtoy P.J., and Constantinescu S.N. Janus kinases affect thrombopoietin receptor cell surface localization and stability. J. Biol. Chem. 280 (2005) 27251
13. Moliterno A.R., Hankins W.D., and Spivak J.L. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N. Engl. J. Med. 338 (1998) 572
14. Moliterno A.R., and Spivak J.L. Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94 (1999) 2555
15. Lu X., Levine R., Tong W., Wernig G., Pikman Y., Zarnegar S., et al. Expression of a type I cytokine receptor is required for JAK2V617F-mediated transformation and for constitutive JAK-STAT activation. Proc. Natl. Acad. Sci. USA 102 (2005) 18962
16. Constantinescu S.N., Keren T., Socolovsky M., Nam H., Henis Y.I., and Lodish H.F. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc. Natl. Acad. Sci. USA 98 (2001) 4379
17. Seubert N., Royer Y., Staerk J., Kubatzky K.F., Moucadel V., Krishnakumar S., et al. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol. Cell 12 (2003) 1239
18. Correa P.N., Eskinazi D., and Axelrad A.A. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 83 (1994) 99
19. Mirza A.M., Correa P.N., and Axelrad A.A. Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 86 (1995) 877